Gabapentin Safety Considerations

High-Risk Drug Combinations

The American Geriatrics Society explicitly warns against concurrent use of gabapentin with opioids and benzodiazepines, as this combination substantially increases respiratory depression, sedation, and mortality risk 1, 2
The combination of three or more CNS-active medications dramatically increases fall risk and should be avoided 1
SNRIs combined with gabapentin significantly increase fall risk, especially in older adults 2
Tricyclic antidepressants with gabapentin cause additive sedation and anticholinergic effects 2
SSRIs combined with gabapentin may increase CNS depression, though less severely than SNRIs 2
Combination therapy with nortriptyline and gabapentin has proven superior to either medication alone for neuropathic pain, but requires careful monitoring for additive sedation 3, 4
Morphine combined with gabapentin allows lower doses of both medications with better pain relief, though adverse effects are not reduced 3, 4
Trimethoprim-sulfamethoxazole combined with gabapentin in patients on ACE inhibitors or ARBs increases hyperkalemia risk 1

Gabapentin is almost exclusively eliminated unchanged by the kidneys, making renal function the single most important factor determining drug accumulation and toxicity risk 5
Calculate creatinine clearance using the Cockcroft-Gault equation before initiating gabapentin 5
Life-threatening accumulation manifests as excessive sedation, dizziness, somnolence, gait disturbance, and confusion 5
Critical distinction: Gabapentin does not cause kidney damage—impaired kidneys affect gabapentin elimination, but gabapentin does not impair kidney function 5

Calculate creatinine clearance (mandatory) before prescribing gabapentin 5
Review all current medications for CNS depressants 1, 2
Assess respiratory function and sleep apnea risk 2
Document fall risk factors 1
Avoid adding opioids, benzodiazepines, or multiple CNS depressants 1, 2
Monitor for excessive sedation, confusion, gait disturbance 5
Consider non-CNS depressant alternatives when additional pain management is needed 2
Taper gradually over minimum 1 week: reduce by 10% of original dose per week when discontinuing 6
Monitor for withdrawal symptoms: drug craving, abdominal pain, tremor, tachycardia when discontinuing 6